Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Pulsed electric field treatment may help shrink untreated liver tumors.

Pulsed electric field treatment may help the immune system fight liver tumors.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

A man's adrenal insufficiency was caused by a pituitary tumor linked to kidney cancer.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Axitinib treatment turned a man's grey hair back to black.

The treatment is safe and shows promise for metastatic breast cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.